nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—migraine—Prednisone—ulcerative colitis	0.496	1	CpDpCtD
Dihydroergotamine—ABCB1—ulcerative colitis	0.195	1	CbGaD
Dihydroergotamine—CYP3A4—Budesonide—ulcerative colitis	0.0266	0.147	CbGbCtD
Dihydroergotamine—ABCB1—Methylprednisolone—ulcerative colitis	0.0198	0.11	CbGbCtD
Dihydroergotamine—ABCB1—Betamethasone—ulcerative colitis	0.0129	0.0713	CbGbCtD
Dihydroergotamine—ABCB1—Prednisolone—ulcerative colitis	0.0127	0.0704	CbGbCtD
Dihydroergotamine—ABCB1—Hydrocortisone—ulcerative colitis	0.012	0.0667	CbGbCtD
Dihydroergotamine—ABCB1—Prednisone—ulcerative colitis	0.012	0.0665	CbGbCtD
Dihydroergotamine—CYP3A4—Methylprednisolone—ulcerative colitis	0.0119	0.0657	CbGbCtD
Dihydroergotamine—CYP3A4—Nicotine—ulcerative colitis	0.0116	0.0641	CbGbCtD
Dihydroergotamine—CYP3A4—Cholecalciferol—ulcerative colitis	0.0104	0.0575	CbGbCtD
Dihydroergotamine—CYP3A4—Triamcinolone—ulcerative colitis	0.009	0.0498	CbGbCtD
Dihydroergotamine—CYP3A4—Betamethasone—ulcerative colitis	0.00772	0.0427	CbGbCtD
Dihydroergotamine—CYP3A4—Prednisolone—ulcerative colitis	0.00762	0.0422	CbGbCtD
Dihydroergotamine—ABCB1—Dexamethasone—ulcerative colitis	0.00749	0.0415	CbGbCtD
Dihydroergotamine—CYP3A4—Hydrocortisone—ulcerative colitis	0.00722	0.04	CbGbCtD
Dihydroergotamine—CYP3A4—Prednisone—ulcerative colitis	0.00719	0.0398	CbGbCtD
Dihydroergotamine—CYP3A4—Dexamethasone—ulcerative colitis	0.00449	0.0249	CbGbCtD
Dihydroergotamine—Acute coronary syndrome—Prednisone—ulcerative colitis	0.000121	0.00114	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000121	0.00114	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Prednisone—ulcerative colitis	0.00012	0.00113	CcSEcCtD
Dihydroergotamine—Dizziness—Budesonide—ulcerative colitis	0.00012	0.00113	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Azathioprine—ulcerative colitis	0.00012	0.00112	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.00012	0.00112	CcSEcCtD
Dihydroergotamine—Malaise—Prednisolone—ulcerative colitis	0.000119	0.00112	CcSEcCtD
Dihydroergotamine—Vertigo—Prednisolone—ulcerative colitis	0.000119	0.00111	CcSEcCtD
Dihydroergotamine—Urticaria—Mesalazine—ulcerative colitis	0.000117	0.0011	CcSEcCtD
Dihydroergotamine—Abdominal pain—Mesalazine—ulcerative colitis	0.000117	0.0011	CcSEcCtD
Dihydroergotamine—Body temperature increased—Mesalazine—ulcerative colitis	0.000117	0.0011	CcSEcCtD
Dihydroergotamine—Malaise—Hydrocortisone—ulcerative colitis	0.000116	0.00109	CcSEcCtD
Dihydroergotamine—Vertigo—Hydrocortisone—ulcerative colitis	0.000116	0.00109	CcSEcCtD
Dihydroergotamine—Vomiting—Budesonide—ulcerative colitis	0.000116	0.00109	CcSEcCtD
Dihydroergotamine—Rash—Budesonide—ulcerative colitis	0.000115	0.00108	CcSEcCtD
Dihydroergotamine—Dermatitis—Budesonide—ulcerative colitis	0.000115	0.00108	CcSEcCtD
Dihydroergotamine—Headache—Budesonide—ulcerative colitis	0.000114	0.00107	CcSEcCtD
Dihydroergotamine—Hypertension—Prednisolone—ulcerative colitis	0.000114	0.00107	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000113	0.00106	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000112	0.00105	CcSEcCtD
Dihydroergotamine—Hypertension—Hydrocortisone—ulcerative colitis	0.000111	0.00104	CcSEcCtD
Dihydroergotamine—Diarrhoea—Azathioprine—ulcerative colitis	0.000111	0.00104	CcSEcCtD
Dihydroergotamine—Discomfort—Prednisolone—ulcerative colitis	0.000111	0.00104	CcSEcCtD
Dihydroergotamine—Myalgia—Hydrocortisone—ulcerative colitis	0.00011	0.00103	CcSEcCtD
Dihydroergotamine—Malaise—Triamcinolone—ulcerative colitis	0.000109	0.00103	CcSEcCtD
Dihydroergotamine—Anxiety—Hydrocortisone—ulcerative colitis	0.000109	0.00103	CcSEcCtD
Dihydroergotamine—Malaise—Methylprednisolone—ulcerative colitis	0.000109	0.00103	CcSEcCtD
Dihydroergotamine—Vertigo—Triamcinolone—ulcerative colitis	0.000109	0.00102	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Mesalazine—ulcerative colitis	0.000109	0.00102	CcSEcCtD
Dihydroergotamine—Vertigo—Methylprednisolone—ulcerative colitis	0.000109	0.00102	CcSEcCtD
Dihydroergotamine—Discomfort—Hydrocortisone—ulcerative colitis	0.000108	0.00102	CcSEcCtD
Dihydroergotamine—Nausea—Budesonide—ulcerative colitis	0.000108	0.00101	CcSEcCtD
Dihydroergotamine—Oedema—Prednisolone—ulcerative colitis	0.000108	0.00101	CcSEcCtD
Dihydroergotamine—Dizziness—Azathioprine—ulcerative colitis	0.000107	0.00101	CcSEcCtD
Dihydroergotamine—Asthenia—Mesalazine—ulcerative colitis	0.000106	0.000996	CcSEcCtD
Dihydroergotamine—Shock—Prednisolone—ulcerative colitis	0.000106	0.000995	CcSEcCtD
Dihydroergotamine—Oedema—Hydrocortisone—ulcerative colitis	0.000105	0.000988	CcSEcCtD
Dihydroergotamine—Tachycardia—Prednisolone—ulcerative colitis	0.000105	0.000987	CcSEcCtD
Dihydroergotamine—Hypertension—Triamcinolone—ulcerative colitis	0.000105	0.000984	CcSEcCtD
Dihydroergotamine—Pruritus—Mesalazine—ulcerative colitis	0.000105	0.000983	CcSEcCtD
Dihydroergotamine—Hypertension—Methylprednisolone—ulcerative colitis	0.000105	0.000982	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000104	0.000978	CcSEcCtD
Dihydroergotamine—Ergotamine—ABCB1—ulcerative colitis	0.000104	0.509	CrCbGaD
Dihydroergotamine—Shock—Hydrocortisone—ulcerative colitis	0.000103	0.000972	CcSEcCtD
Dihydroergotamine—Myalgia—Triamcinolone—ulcerative colitis	0.000103	0.00097	CcSEcCtD
Dihydroergotamine—Vomiting—Azathioprine—ulcerative colitis	0.000103	0.000969	CcSEcCtD
Dihydroergotamine—Myalgia—Methylprednisolone—ulcerative colitis	0.000103	0.000968	CcSEcCtD
Dihydroergotamine—Arthralgia—Methylprednisolone—ulcerative colitis	0.000103	0.000968	CcSEcCtD
Dihydroergotamine—Anxiety—Methylprednisolone—ulcerative colitis	0.000103	0.000965	CcSEcCtD
Dihydroergotamine—Tachycardia—Hydrocortisone—ulcerative colitis	0.000103	0.000964	CcSEcCtD
Dihydroergotamine—Rash—Azathioprine—ulcerative colitis	0.000102	0.000961	CcSEcCtD
Dihydroergotamine—Dermatitis—Azathioprine—ulcerative colitis	0.000102	0.00096	CcSEcCtD
Dihydroergotamine—Flushing—Prednisone—ulcerative colitis	0.000102	0.00096	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000102	0.000959	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000102	0.000959	CcSEcCtD
Dihydroergotamine—Discomfort—Triamcinolone—ulcerative colitis	0.000102	0.000958	CcSEcCtD
Dihydroergotamine—Discomfort—Methylprednisolone—ulcerative colitis	0.000102	0.000956	CcSEcCtD
Dihydroergotamine—Headache—Azathioprine—ulcerative colitis	0.000102	0.000955	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000102	0.000955	CcSEcCtD
Dihydroergotamine—Diarrhoea—Mesalazine—ulcerative colitis	0.000101	0.00095	CcSEcCtD
Dihydroergotamine—Dry mouth—Triamcinolone—ulcerative colitis	0.000101	0.000949	CcSEcCtD
Dihydroergotamine—Bromocriptine—ABCB1—ulcerative colitis	0.0001	0.491	CrCbGaD
Dihydroergotamine—Anorexia—Hydrocortisone—ulcerative colitis	0.0001	0.000941	CcSEcCtD
Dihydroergotamine—Confusional state—Methylprednisolone—ulcerative colitis	9.96e-05	0.000936	CcSEcCtD
Dihydroergotamine—Malaise—Dexamethasone—ulcerative colitis	9.93e-05	0.000932	CcSEcCtD
Dihydroergotamine—Malaise—Betamethasone—ulcerative colitis	9.93e-05	0.000932	CcSEcCtD
Dihydroergotamine—Oedema—Triamcinolone—ulcerative colitis	9.9e-05	0.00093	CcSEcCtD
Dihydroergotamine—Vertigo—Betamethasone—ulcerative colitis	9.89e-05	0.000929	CcSEcCtD
Dihydroergotamine—Vertigo—Dexamethasone—ulcerative colitis	9.89e-05	0.000929	CcSEcCtD
Dihydroergotamine—Hypotension—Hydrocortisone—ulcerative colitis	9.83e-05	0.000923	CcSEcCtD
Dihydroergotamine—Dizziness—Mesalazine—ulcerative colitis	9.78e-05	0.000918	CcSEcCtD
Dihydroergotamine—Shock—Triamcinolone—ulcerative colitis	9.74e-05	0.000915	CcSEcCtD
Dihydroergotamine—Insomnia—Prednisolone—ulcerative colitis	9.74e-05	0.000915	CcSEcCtD
Dihydroergotamine—Shock—Methylprednisolone—ulcerative colitis	9.72e-05	0.000913	CcSEcCtD
Dihydroergotamine—Paraesthesia—Prednisolone—ulcerative colitis	9.67e-05	0.000908	CcSEcCtD
Dihydroergotamine—Tachycardia—Triamcinolone—ulcerative colitis	9.66e-05	0.000908	CcSEcCtD
Dihydroergotamine—Nausea—Azathioprine—ulcerative colitis	9.64e-05	0.000906	CcSEcCtD
Dihydroergotamine—Tachycardia—Methylprednisolone—ulcerative colitis	9.64e-05	0.000906	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	9.58e-05	0.0009	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Triamcinolone—ulcerative colitis	9.57e-05	0.000899	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	9.55e-05	0.000897	CcSEcCtD
Dihydroergotamine—Insomnia—Hydrocortisone—ulcerative colitis	9.51e-05	0.000893	CcSEcCtD
Dihydroergotamine—Hypertension—Dexamethasone—ulcerative colitis	9.5e-05	0.000893	CcSEcCtD
Dihydroergotamine—Hypertension—Betamethasone—ulcerative colitis	9.5e-05	0.000893	CcSEcCtD
Dihydroergotamine—Paraesthesia—Hydrocortisone—ulcerative colitis	9.44e-05	0.000887	CcSEcCtD
Dihydroergotamine—Vomiting—Mesalazine—ulcerative colitis	9.4e-05	0.000883	CcSEcCtD
Dihydroergotamine—Myalgia—Dexamethasone—ulcerative colitis	9.37e-05	0.00088	CcSEcCtD
Dihydroergotamine—Myalgia—Betamethasone—ulcerative colitis	9.37e-05	0.00088	CcSEcCtD
Dihydroergotamine—Anxiety—Dexamethasone—ulcerative colitis	9.34e-05	0.000877	CcSEcCtD
Dihydroergotamine—Anxiety—Betamethasone—ulcerative colitis	9.34e-05	0.000877	CcSEcCtD
Dihydroergotamine—Rash—Mesalazine—ulcerative colitis	9.32e-05	0.000876	CcSEcCtD
Dihydroergotamine—Dermatitis—Mesalazine—ulcerative colitis	9.31e-05	0.000875	CcSEcCtD
Dihydroergotamine—Headache—Mesalazine—ulcerative colitis	9.26e-05	0.00087	CcSEcCtD
Dihydroergotamine—Discomfort—Betamethasone—ulcerative colitis	9.26e-05	0.00087	CcSEcCtD
Dihydroergotamine—Discomfort—Dexamethasone—ulcerative colitis	9.26e-05	0.00087	CcSEcCtD
Dihydroergotamine—Dyspepsia—Hydrocortisone—ulcerative colitis	9.26e-05	0.000869	CcSEcCtD
Dihydroergotamine—Hypotension—Methylprednisolone—ulcerative colitis	9.23e-05	0.000867	CcSEcCtD
Dihydroergotamine—Pain—Prednisolone—ulcerative colitis	9.21e-05	0.000865	CcSEcCtD
Dihydroergotamine—Decreased appetite—Hydrocortisone—ulcerative colitis	9.14e-05	0.000859	CcSEcCtD
Dihydroergotamine—Fatigue—Hydrocortisone—ulcerative colitis	9.07e-05	0.000851	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	9.02e-05	0.000847	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	9e-05	0.000845	CcSEcCtD
Dihydroergotamine—Pain—Hydrocortisone—ulcerative colitis	8.99e-05	0.000845	CcSEcCtD
Dihydroergotamine—Oedema—Dexamethasone—ulcerative colitis	8.98e-05	0.000844	CcSEcCtD
Dihydroergotamine—Oedema—Betamethasone—ulcerative colitis	8.98e-05	0.000844	CcSEcCtD
Dihydroergotamine—Insomnia—Triamcinolone—ulcerative colitis	8.95e-05	0.000841	CcSEcCtD
Dihydroergotamine—Insomnia—Methylprednisolone—ulcerative colitis	8.93e-05	0.000839	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Prednisone—ulcerative colitis	8.89e-05	0.000835	CcSEcCtD
Dihydroergotamine—Paraesthesia—Triamcinolone—ulcerative colitis	8.89e-05	0.000835	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Prednisolone—ulcerative colitis	8.87e-05	0.000833	CcSEcCtD
Dihydroergotamine—Paraesthesia—Methylprednisolone—ulcerative colitis	8.87e-05	0.000833	CcSEcCtD
Dihydroergotamine—Shock—Betamethasone—ulcerative colitis	8.84e-05	0.00083	CcSEcCtD
Dihydroergotamine—Shock—Dexamethasone—ulcerative colitis	8.84e-05	0.00083	CcSEcCtD
Dihydroergotamine—Dyspnoea—Triamcinolone—ulcerative colitis	8.83e-05	0.000829	CcSEcCtD
Dihydroergotamine—Agitation—Prednisone—ulcerative colitis	8.81e-05	0.000827	CcSEcCtD
Dihydroergotamine—Nausea—Mesalazine—ulcerative colitis	8.78e-05	0.000825	CcSEcCtD
Dihydroergotamine—Tachycardia—Betamethasone—ulcerative colitis	8.77e-05	0.000824	CcSEcCtD
Dihydroergotamine—Tachycardia—Dexamethasone—ulcerative colitis	8.77e-05	0.000824	CcSEcCtD
Dihydroergotamine—Dyspepsia—Triamcinolone—ulcerative colitis	8.72e-05	0.000819	CcSEcCtD
Dihydroergotamine—Dyspepsia—Methylprednisolone—ulcerative colitis	8.7e-05	0.000817	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Dexamethasone—ulcerative colitis	8.68e-05	0.000816	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Betamethasone—ulcerative colitis	8.68e-05	0.000816	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Hydrocortisone—ulcerative colitis	8.66e-05	0.000814	CcSEcCtD
Dihydroergotamine—Malaise—Prednisone—ulcerative colitis	8.64e-05	0.000812	CcSEcCtD
Dihydroergotamine—Vertigo—Prednisone—ulcerative colitis	8.61e-05	0.000809	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	8.6e-05	0.000808	CcSEcCtD
Dihydroergotamine—Anorexia—Betamethasone—ulcerative colitis	8.56e-05	0.000804	CcSEcCtD
Dihydroergotamine—Anorexia—Dexamethasone—ulcerative colitis	8.56e-05	0.000804	CcSEcCtD
Dihydroergotamine—Urticaria—Prednisolone—ulcerative colitis	8.55e-05	0.000803	CcSEcCtD
Dihydroergotamine—Fatigue—Triamcinolone—ulcerative colitis	8.54e-05	0.000802	CcSEcCtD
Dihydroergotamine—Fatigue—Methylprednisolone—ulcerative colitis	8.52e-05	0.0008	CcSEcCtD
Dihydroergotamine—Pain—Triamcinolone—ulcerative colitis	8.47e-05	0.000795	CcSEcCtD
Dihydroergotamine—Hypotension—Dexamethasone—ulcerative colitis	8.39e-05	0.000788	CcSEcCtD
Dihydroergotamine—Hypotension—Betamethasone—ulcerative colitis	8.39e-05	0.000788	CcSEcCtD
Dihydroergotamine—Urticaria—Hydrocortisone—ulcerative colitis	8.35e-05	0.000785	CcSEcCtD
Dihydroergotamine—Abdominal pain—Hydrocortisone—ulcerative colitis	8.31e-05	0.000781	CcSEcCtD
Dihydroergotamine—Body temperature increased—Hydrocortisone—ulcerative colitis	8.31e-05	0.000781	CcSEcCtD
Dihydroergotamine—Hypertension—Prednisone—ulcerative colitis	8.28e-05	0.000777	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	8.18e-05	0.000769	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	8.18e-05	0.000769	CcSEcCtD
Dihydroergotamine—Arthralgia—Prednisone—ulcerative colitis	8.16e-05	0.000767	CcSEcCtD
Dihydroergotamine—Myalgia—Prednisone—ulcerative colitis	8.16e-05	0.000767	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Triamcinolone—ulcerative colitis	8.16e-05	0.000766	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Methylprednisolone—ulcerative colitis	8.14e-05	0.000765	CcSEcCtD
Dihydroergotamine—Anxiety—Prednisone—ulcerative colitis	8.13e-05	0.000764	CcSEcCtD
Dihydroergotamine—Insomnia—Dexamethasone—ulcerative colitis	8.13e-05	0.000763	CcSEcCtD
Dihydroergotamine—Insomnia—Betamethasone—ulcerative colitis	8.13e-05	0.000763	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	8.08e-05	0.000759	CcSEcCtD
Dihydroergotamine—Paraesthesia—Betamethasone—ulcerative colitis	8.07e-05	0.000758	CcSEcCtD
Dihydroergotamine—Paraesthesia—Dexamethasone—ulcerative colitis	8.07e-05	0.000758	CcSEcCtD
Dihydroergotamine—Discomfort—Prednisone—ulcerative colitis	8.06e-05	0.000757	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Prednisolone—ulcerative colitis	7.93e-05	0.000745	CcSEcCtD
Dihydroergotamine—Dyspepsia—Betamethasone—ulcerative colitis	7.91e-05	0.000743	CcSEcCtD
Dihydroergotamine—Dyspepsia—Dexamethasone—ulcerative colitis	7.91e-05	0.000743	CcSEcCtD
Dihydroergotamine—Urticaria—Triamcinolone—ulcerative colitis	7.87e-05	0.000739	CcSEcCtD
Dihydroergotamine—Urticaria—Methylprednisolone—ulcerative colitis	7.85e-05	0.000737	CcSEcCtD
Dihydroergotamine—Body temperature increased—Triamcinolone—ulcerative colitis	7.83e-05	0.000735	CcSEcCtD
Dihydroergotamine—Oedema—Prednisone—ulcerative colitis	7.82e-05	0.000735	CcSEcCtD
Dihydroergotamine—Abdominal pain—Methylprednisolone—ulcerative colitis	7.81e-05	0.000733	CcSEcCtD
Dihydroergotamine—Decreased appetite—Dexamethasone—ulcerative colitis	7.81e-05	0.000733	CcSEcCtD
Dihydroergotamine—Decreased appetite—Betamethasone—ulcerative colitis	7.81e-05	0.000733	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Hydrocortisone—ulcerative colitis	7.75e-05	0.000728	CcSEcCtD
Dihydroergotamine—Fatigue—Betamethasone—ulcerative colitis	7.75e-05	0.000727	CcSEcCtD
Dihydroergotamine—Fatigue—Dexamethasone—ulcerative colitis	7.75e-05	0.000727	CcSEcCtD
Dihydroergotamine—Shock—Prednisone—ulcerative colitis	7.7e-05	0.000723	CcSEcCtD
Dihydroergotamine—Pain—Dexamethasone—ulcerative colitis	7.68e-05	0.000722	CcSEcCtD
Dihydroergotamine—Pain—Betamethasone—ulcerative colitis	7.68e-05	0.000722	CcSEcCtD
Dihydroergotamine—Tachycardia—Prednisone—ulcerative colitis	7.64e-05	0.000717	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Prednisone—ulcerative colitis	7.56e-05	0.00071	CcSEcCtD
Dihydroergotamine—Asthenia—Hydrocortisone—ulcerative colitis	7.54e-05	0.000709	CcSEcCtD
Dihydroergotamine—Anorexia—Prednisone—ulcerative colitis	7.46e-05	0.0007	CcSEcCtD
Dihydroergotamine—Pruritus—Hydrocortisone—ulcerative colitis	7.44e-05	0.000699	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Dexamethasone—ulcerative colitis	7.4e-05	0.000695	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Betamethasone—ulcerative colitis	7.4e-05	0.000695	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	7.35e-05	0.00069	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Betamethasone—ulcerative colitis	7.35e-05	0.00069	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Triamcinolone—ulcerative colitis	7.29e-05	0.000685	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Methylprednisolone—ulcerative colitis	7.28e-05	0.000684	CcSEcCtD
Dihydroergotamine—Diarrhoea—Hydrocortisone—ulcerative colitis	7.19e-05	0.000676	CcSEcCtD
Dihydroergotamine—Urticaria—Dexamethasone—ulcerative colitis	7.14e-05	0.00067	CcSEcCtD
Dihydroergotamine—Urticaria—Betamethasone—ulcerative colitis	7.14e-05	0.00067	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	7.13e-05	0.000669	CcSEcCtD
Dihydroergotamine—Dizziness—Prednisolone—ulcerative colitis	7.12e-05	0.000669	CcSEcCtD
Dihydroergotamine—Asthenia—Triamcinolone—ulcerative colitis	7.1e-05	0.000667	CcSEcCtD
Dihydroergotamine—Body temperature increased—Betamethasone—ulcerative colitis	7.1e-05	0.000667	CcSEcCtD
Dihydroergotamine—Body temperature increased—Dexamethasone—ulcerative colitis	7.1e-05	0.000667	CcSEcCtD
Dihydroergotamine—Abdominal pain—Dexamethasone—ulcerative colitis	7.1e-05	0.000667	CcSEcCtD
Dihydroergotamine—Abdominal pain—Betamethasone—ulcerative colitis	7.1e-05	0.000667	CcSEcCtD
Dihydroergotamine—Asthenia—Methylprednisolone—ulcerative colitis	7.09e-05	0.000666	CcSEcCtD
Dihydroergotamine—Insomnia—Prednisone—ulcerative colitis	7.08e-05	0.000665	CcSEcCtD
Dihydroergotamine—Paraesthesia—Prednisone—ulcerative colitis	7.02e-05	0.00066	CcSEcCtD
Dihydroergotamine—Pruritus—Triamcinolone—ulcerative colitis	7e-05	0.000658	CcSEcCtD
Dihydroergotamine—Pruritus—Methylprednisolone—ulcerative colitis	6.99e-05	0.000656	CcSEcCtD
Dihydroergotamine—Dizziness—Hydrocortisone—ulcerative colitis	6.95e-05	0.000653	CcSEcCtD
Dihydroergotamine—Dyspepsia—Prednisone—ulcerative colitis	6.89e-05	0.000647	CcSEcCtD
Dihydroergotamine—Decreased appetite—Prednisone—ulcerative colitis	6.8e-05	0.000639	CcSEcCtD
Dihydroergotamine—Rash—Prednisolone—ulcerative colitis	6.79e-05	0.000638	CcSEcCtD
Dihydroergotamine—Dermatitis—Prednisolone—ulcerative colitis	6.78e-05	0.000637	CcSEcCtD
Dihydroergotamine—Diarrhoea—Methylprednisolone—ulcerative colitis	6.76e-05	0.000635	CcSEcCtD
Dihydroergotamine—Fatigue—Prednisone—ulcerative colitis	6.74e-05	0.000634	CcSEcCtD
Dihydroergotamine—Headache—Prednisolone—ulcerative colitis	6.74e-05	0.000633	CcSEcCtD
Dihydroergotamine—Vomiting—Hydrocortisone—ulcerative colitis	6.69e-05	0.000628	CcSEcCtD
Dihydroergotamine—Rash—Hydrocortisone—ulcerative colitis	6.63e-05	0.000623	CcSEcCtD
Dihydroergotamine—Dermatitis—Hydrocortisone—ulcerative colitis	6.62e-05	0.000622	CcSEcCtD
Dihydroergotamine—Headache—Hydrocortisone—ulcerative colitis	6.59e-05	0.000619	CcSEcCtD
Dihydroergotamine—Dizziness—Triamcinolone—ulcerative colitis	6.55e-05	0.000615	CcSEcCtD
Dihydroergotamine—Dizziness—Methylprednisolone—ulcerative colitis	6.53e-05	0.000614	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Prednisone—ulcerative colitis	6.45e-05	0.000606	CcSEcCtD
Dihydroergotamine—Asthenia—Dexamethasone—ulcerative colitis	6.45e-05	0.000605	CcSEcCtD
Dihydroergotamine—Asthenia—Betamethasone—ulcerative colitis	6.45e-05	0.000605	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Prednisone—ulcerative colitis	6.4e-05	0.000601	CcSEcCtD
Dihydroergotamine—Nausea—Prednisolone—ulcerative colitis	6.39e-05	0.000601	CcSEcCtD
Dihydroergotamine—Pruritus—Dexamethasone—ulcerative colitis	6.36e-05	0.000597	CcSEcCtD
Dihydroergotamine—Pruritus—Betamethasone—ulcerative colitis	6.36e-05	0.000597	CcSEcCtD
Dihydroergotamine—Vomiting—Triamcinolone—ulcerative colitis	6.29e-05	0.000591	CcSEcCtD
Dihydroergotamine—Vomiting—Methylprednisolone—ulcerative colitis	6.28e-05	0.00059	CcSEcCtD
Dihydroergotamine—Nausea—Hydrocortisone—ulcerative colitis	6.25e-05	0.000587	CcSEcCtD
Dihydroergotamine—Rash—Triamcinolone—ulcerative colitis	6.24e-05	0.000586	CcSEcCtD
Dihydroergotamine—Dermatitis—Triamcinolone—ulcerative colitis	6.24e-05	0.000586	CcSEcCtD
Dihydroergotamine—Rash—Methylprednisolone—ulcerative colitis	6.23e-05	0.000585	CcSEcCtD
Dihydroergotamine—Dermatitis—Methylprednisolone—ulcerative colitis	6.22e-05	0.000584	CcSEcCtD
Dihydroergotamine—Urticaria—Prednisone—ulcerative colitis	6.22e-05	0.000584	CcSEcCtD
Dihydroergotamine—Headache—Triamcinolone—ulcerative colitis	6.2e-05	0.000583	CcSEcCtD
Dihydroergotamine—Headache—Methylprednisolone—ulcerative colitis	6.19e-05	0.000581	CcSEcCtD
Dihydroergotamine—Abdominal pain—Prednisone—ulcerative colitis	6.18e-05	0.000581	CcSEcCtD
Dihydroergotamine—Body temperature increased—Prednisone—ulcerative colitis	6.18e-05	0.000581	CcSEcCtD
Dihydroergotamine—Diarrhoea—Betamethasone—ulcerative colitis	6.15e-05	0.000577	CcSEcCtD
Dihydroergotamine—Diarrhoea—Dexamethasone—ulcerative colitis	6.15e-05	0.000577	CcSEcCtD
Dihydroergotamine—Dizziness—Dexamethasone—ulcerative colitis	5.94e-05	0.000558	CcSEcCtD
Dihydroergotamine—Dizziness—Betamethasone—ulcerative colitis	5.94e-05	0.000558	CcSEcCtD
Dihydroergotamine—Nausea—Triamcinolone—ulcerative colitis	5.88e-05	0.000552	CcSEcCtD
Dihydroergotamine—Nausea—Methylprednisolone—ulcerative colitis	5.87e-05	0.000551	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Prednisone—ulcerative colitis	5.76e-05	0.000541	CcSEcCtD
Dihydroergotamine—Vomiting—Betamethasone—ulcerative colitis	5.71e-05	0.000536	CcSEcCtD
Dihydroergotamine—Vomiting—Dexamethasone—ulcerative colitis	5.71e-05	0.000536	CcSEcCtD
Dihydroergotamine—Rash—Dexamethasone—ulcerative colitis	5.66e-05	0.000532	CcSEcCtD
Dihydroergotamine—Rash—Betamethasone—ulcerative colitis	5.66e-05	0.000532	CcSEcCtD
Dihydroergotamine—Dermatitis—Dexamethasone—ulcerative colitis	5.66e-05	0.000532	CcSEcCtD
Dihydroergotamine—Dermatitis—Betamethasone—ulcerative colitis	5.66e-05	0.000532	CcSEcCtD
Dihydroergotamine—Headache—Dexamethasone—ulcerative colitis	5.63e-05	0.000529	CcSEcCtD
Dihydroergotamine—Headache—Betamethasone—ulcerative colitis	5.63e-05	0.000529	CcSEcCtD
Dihydroergotamine—Asthenia—Prednisone—ulcerative colitis	5.61e-05	0.000527	CcSEcCtD
Dihydroergotamine—Pruritus—Prednisone—ulcerative colitis	5.53e-05	0.00052	CcSEcCtD
Dihydroergotamine—Diarrhoea—Prednisone—ulcerative colitis	5.35e-05	0.000503	CcSEcCtD
Dihydroergotamine—Nausea—Betamethasone—ulcerative colitis	5.34e-05	0.000501	CcSEcCtD
Dihydroergotamine—Nausea—Dexamethasone—ulcerative colitis	5.34e-05	0.000501	CcSEcCtD
Dihydroergotamine—Dizziness—Prednisone—ulcerative colitis	5.17e-05	0.000486	CcSEcCtD
Dihydroergotamine—Vomiting—Prednisone—ulcerative colitis	4.97e-05	0.000467	CcSEcCtD
Dihydroergotamine—Rash—Prednisone—ulcerative colitis	4.93e-05	0.000463	CcSEcCtD
Dihydroergotamine—Dermatitis—Prednisone—ulcerative colitis	4.93e-05	0.000463	CcSEcCtD
Dihydroergotamine—Headache—Prednisone—ulcerative colitis	4.9e-05	0.00046	CcSEcCtD
Dihydroergotamine—Nausea—Prednisone—ulcerative colitis	4.65e-05	0.000436	CcSEcCtD
Dihydroergotamine—HTR1D—Signaling by GPCR—ADRB2—ulcerative colitis	1.81e-05	0.000843	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—GNA12—ulcerative colitis	1.8e-05	0.000838	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—GHRL—ulcerative colitis	1.8e-05	0.000837	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—GNA12—ulcerative colitis	1.78e-05	0.000831	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—PTGER4—ulcerative colitis	1.78e-05	0.00083	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—ADRB2—ulcerative colitis	1.77e-05	0.000826	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—GNA12—ulcerative colitis	1.76e-05	0.00082	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCL20—ulcerative colitis	1.76e-05	0.00082	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CCR6—ulcerative colitis	1.75e-05	0.000816	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.75e-05	0.000815	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CXCR2—ulcerative colitis	1.72e-05	0.0008	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—CXCL8—ulcerative colitis	1.72e-05	0.0008	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—ADCY5—ulcerative colitis	1.7e-05	0.000794	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CXCR2—ulcerative colitis	1.7e-05	0.000794	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—CXCL8—ulcerative colitis	1.7e-05	0.000794	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—ADCY5—ulcerative colitis	1.69e-05	0.000788	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CXCR2—ulcerative colitis	1.69e-05	0.000788	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CXCR2—ulcerative colitis	1.67e-05	0.000778	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.67e-05	0.000777	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—CXCL8—ulcerative colitis	1.67e-05	0.000777	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—ADRB2—ulcerative colitis	1.66e-05	0.000776	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—ADCY5—ulcerative colitis	1.66e-05	0.000772	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	1.66e-05	0.000771	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—GNA12—ulcerative colitis	1.65e-05	0.000771	CbGpPWpGaD
Dihydroergotamine—ADRA2A—G alpha (i) signalling events—CXCL8—ulcerative colitis	1.65e-05	0.000768	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—IL6—ulcerative colitis	1.64e-05	0.000762	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—GHRL—ulcerative colitis	1.63e-05	0.00076	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CXCR1—ulcerative colitis	1.62e-05	0.000757	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CCR6—ulcerative colitis	1.61e-05	0.000752	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CHP1—ulcerative colitis	1.61e-05	0.000752	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CCR6—ulcerative colitis	1.6e-05	0.000747	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CCR6—ulcerative colitis	1.59e-05	0.000741	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CALM3—ulcerative colitis	1.58e-05	0.000736	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CCR6—ulcerative colitis	1.57e-05	0.000731	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CXCR2—ulcerative colitis	1.57e-05	0.00073	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—CXCL8—ulcerative colitis	1.57e-05	0.00073	CbGpPWpGaD
Dihydroergotamine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.56e-05	0.000727	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—ADCY5—ulcerative colitis	1.56e-05	0.000725	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—SEL1L—ulcerative colitis	1.55e-05	0.000723	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—ADCY5—ulcerative colitis	1.55e-05	0.000721	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—PTGER4—ulcerative colitis	1.54e-05	0.000718	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—ADCY5—ulcerative colitis	1.54e-05	0.000716	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—MAML2—ulcerative colitis	1.53e-05	0.000713	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—MAML2—ulcerative colitis	1.52e-05	0.000708	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—ADCY5—ulcerative colitis	1.5e-05	0.000701	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—MAML2—ulcerative colitis	1.49e-05	0.000693	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—ADRB2—ulcerative colitis	1.49e-05	0.000693	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCR6—ulcerative colitis	1.47e-05	0.000687	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCL20—ulcerative colitis	1.43e-05	0.000665	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—PTGER4—ulcerative colitis	1.42e-05	0.000662	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—ADCY5—ulcerative colitis	1.41e-05	0.000658	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—GHRL—ulcerative colitis	1.41e-05	0.000658	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—PTGER4—ulcerative colitis	1.41e-05	0.000657	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—PTGER4—ulcerative colitis	1.4e-05	0.000652	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—MAML2—ulcerative colitis	1.4e-05	0.000651	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—DLD—ulcerative colitis	1.39e-05	0.000649	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—MMP1—ulcerative colitis	1.39e-05	0.000647	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.39e-05	0.000647	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—PTGER4—ulcerative colitis	1.38e-05	0.000644	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—ADRB2—ulcerative colitis	1.35e-05	0.000629	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—GNA12—ulcerative colitis	1.34e-05	0.000625	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.31e-05	0.000611	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—GHRL—ulcerative colitis	1.3e-05	0.000606	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PTGER4—ulcerative colitis	1.3e-05	0.000605	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—GHRL—ulcerative colitis	1.29e-05	0.000602	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	1.29e-05	0.000602	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—GHRL—ulcerative colitis	1.28e-05	0.000597	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCR1—ulcerative colitis	1.28e-05	0.000595	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CXCR2—ulcerative colitis	1.27e-05	0.000592	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—CXCL8—ulcerative colitis	1.27e-05	0.000592	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—GHRL—ulcerative colitis	1.26e-05	0.000589	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.26e-05	0.000588	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CALM3—ulcerative colitis	1.26e-05	0.000587	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CALM3—ulcerative colitis	1.25e-05	0.000583	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—RIPK2—ulcerative colitis	1.24e-05	0.000579	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CALM3—ulcerative colitis	1.24e-05	0.000578	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—RIPK2—ulcerative colitis	1.23e-05	0.000574	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CALM3—ulcerative colitis	1.22e-05	0.000571	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—RIPK2—ulcerative colitis	1.21e-05	0.000562	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.2e-05	0.000561	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCR6—ulcerative colitis	1.19e-05	0.000557	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—GHRL—ulcerative colitis	1.19e-05	0.000554	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—ADRB2—ulcerative colitis	1.17e-05	0.000544	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CALM3—ulcerative colitis	1.15e-05	0.000536	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—ADCY5—ulcerative colitis	1.15e-05	0.000534	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—RIPK2—ulcerative colitis	1.13e-05	0.000528	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—MAML2—ulcerative colitis	1.13e-05	0.000528	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCL20—ulcerative colitis	1.12e-05	0.000522	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—ADRB2—ulcerative colitis	1.08e-05	0.000502	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—ADRB2—ulcerative colitis	1.07e-05	0.000498	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—JAK2—ulcerative colitis	1.06e-05	0.000495	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—ADRB2—ulcerative colitis	1.06e-05	0.000494	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—JAK2—ulcerative colitis	1.05e-05	0.000491	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—GNA12—ulcerative colitis	1.05e-05	0.000491	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—ALB—ulcerative colitis	1.05e-05	0.00049	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PTGER4—ulcerative colitis	1.05e-05	0.00049	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—ADRB2—ulcerative colitis	1.05e-05	0.000488	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—JAK2—ulcerative colitis	1.03e-05	0.000481	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1e-05	0.000468	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCR2—ulcerative colitis	9.99e-06	0.000466	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—CXCL8—ulcerative colitis	9.98e-06	0.000465	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CHP1—ulcerative colitis	9.94e-06	0.000463	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—ADCY5—ulcerative colitis	9.91e-06	0.000462	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—ADRB2—ulcerative colitis	9.83e-06	0.000458	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—JAK2—ulcerative colitis	9.78e-06	0.000456	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PTGS1—ulcerative colitis	9.74e-06	0.000454	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—JAK2—ulcerative colitis	9.7e-06	0.000452	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—CXCL8—ulcerative colitis	9.7e-06	0.000452	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—JAK2—ulcerative colitis	9.65e-06	0.00045	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—GHRL—ulcerative colitis	9.63e-06	0.000449	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—CXCL8—ulcerative colitis	9.62e-06	0.000449	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—JAK2—ulcerative colitis	9.57e-06	0.000446	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—CXCL8—ulcerative colitis	9.42e-06	0.000439	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCR6—ulcerative colitis	9.39e-06	0.000438	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	9.39e-06	0.000438	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—JAK2—ulcerative colitis	9.37e-06	0.000437	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	9.37e-06	0.000437	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CALM3—ulcerative colitis	9.33e-06	0.000435	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—IL2—ulcerative colitis	9.27e-06	0.000432	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—IL2—ulcerative colitis	9.2e-06	0.000429	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—RIPK2—ulcerative colitis	9.19e-06	0.000428	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—ADCY5—ulcerative colitis	9.14e-06	0.000426	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—ADCY5—ulcerative colitis	9.07e-06	0.000423	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—IL2—ulcerative colitis	9e-06	0.00042	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—ADCY5—ulcerative colitis	9e-06	0.00042	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—MAML2—ulcerative colitis	8.9e-06	0.000415	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—ADCY5—ulcerative colitis	8.88e-06	0.000414	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—CXCL8—ulcerative colitis	8.85e-06	0.000413	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—JAK2—ulcerative colitis	8.81e-06	0.00041	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—CXCL8—ulcerative colitis	8.81e-06	0.00041	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CALM3—ulcerative colitis	8.77e-06	0.000409	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—CXCL8—ulcerative colitis	8.74e-06	0.000407	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—DLD—ulcerative colitis	8.58e-06	0.0004	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—CXCL8—ulcerative colitis	8.56e-06	0.000399	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—IL2—ulcerative colitis	8.53e-06	0.000398	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—IL2—ulcerative colitis	8.46e-06	0.000394	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—IL2—ulcerative colitis	8.42e-06	0.000392	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—IL2—ulcerative colitis	8.35e-06	0.000389	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—ADCY5—ulcerative colitis	8.34e-06	0.000389	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PTGER4—ulcerative colitis	8.27e-06	0.000385	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	8.26e-06	0.000385	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—IL2—ulcerative colitis	8.18e-06	0.000381	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CXCL8—ulcerative colitis	8.04e-06	0.000375	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—ADRB2—ulcerative colitis	7.97e-06	0.000372	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—JAK2—ulcerative colitis	7.86e-06	0.000367	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—IL2—ulcerative colitis	7.68e-06	0.000358	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	7.57e-06	0.000353	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	7.33e-06	0.000342	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	7.22e-06	0.000337	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CXCL8—ulcerative colitis	7.18e-06	0.000335	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—JAK2—ulcerative colitis	7.14e-06	0.000333	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—IL2—ulcerative colitis	6.86e-06	0.00032	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—ABCB1—ulcerative colitis	6.82e-06	0.000318	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—ADCY5—ulcerative colitis	6.77e-06	0.000315	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PTGS1—ulcerative colitis	6.73e-06	0.000314	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	6.65e-06	0.00031	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CXCL8—ulcerative colitis	6.52e-06	0.000304	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—ADCY5—ulcerative colitis	6.36e-06	0.000296	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.3e-06	0.000294	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	6.27e-06	0.000292	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—IL2—ulcerative colitis	6.23e-06	0.00029	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	6.18e-06	0.000288	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CALM3—ulcerative colitis	6.06e-06	0.000283	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—JAK2—ulcerative colitis	5.7e-06	0.000266	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—JAK2—ulcerative colitis	5.66e-06	0.000264	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	5.64e-06	0.000263	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	5.61e-06	0.000262	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—JAK2—ulcerative colitis	5.54e-06	0.000258	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—RELA—ulcerative colitis	5.52e-06	0.000257	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—TP53—ulcerative colitis	5.48e-06	0.000255	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—RELA—ulcerative colitis	5.48e-06	0.000255	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	5.39e-06	0.000251	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—RELA—ulcerative colitis	5.36e-06	0.00025	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	5.32e-06	0.000248	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—JAK2—ulcerative colitis	5.2e-06	0.000242	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CXCL8—ulcerative colitis	5.2e-06	0.000242	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CXCL8—ulcerative colitis	5.16e-06	0.000241	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	5.12e-06	0.000239	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CXCL8—ulcerative colitis	5.05e-06	0.000236	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—RELA—ulcerative colitis	5.04e-06	0.000235	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IL2—ulcerative colitis	4.97e-06	0.000232	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—IL6—ulcerative colitis	4.95e-06	0.000231	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IL2—ulcerative colitis	4.93e-06	0.00023	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—IL6—ulcerative colitis	4.91e-06	0.000229	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	4.9e-06	0.000228	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL2—ulcerative colitis	4.83e-06	0.000225	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—IL6—ulcerative colitis	4.81e-06	0.000224	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CXCL8—ulcerative colitis	4.75e-06	0.000221	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PPARG—ulcerative colitis	4.74e-06	0.000221	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—MMP9—ulcerative colitis	4.7e-06	0.000219	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—MMP9—ulcerative colitis	4.67e-06	0.000218	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NFKB1—ulcerative colitis	4.65e-06	0.000217	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NFKB1—ulcerative colitis	4.62e-06	0.000215	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—MMP9—ulcerative colitis	4.57e-06	0.000213	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL2—ulcerative colitis	4.54e-06	0.000212	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NFKB1—ulcerative colitis	4.52e-06	0.000211	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—IL6—ulcerative colitis	4.51e-06	0.00021	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ADCY5—ulcerative colitis	4.4e-06	0.000205	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—MMP9—ulcerative colitis	4.29e-06	0.0002	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—ALB—ulcerative colitis	4.27e-06	0.000199	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NFKB1—ulcerative colitis	4.25e-06	0.000198	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—JAK2—ulcerative colitis	4.22e-06	0.000197	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—STAT3—ulcerative colitis	4.18e-06	0.000195	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—STAT3—ulcerative colitis	4.15e-06	0.000193	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PTGS1—ulcerative colitis	4.15e-06	0.000193	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—RELA—ulcerative colitis	4.09e-06	0.00019	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—STAT3—ulcerative colitis	4.06e-06	0.000189	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TGFB1—ulcerative colitis	3.88e-06	0.000181	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CXCL8—ulcerative colitis	3.85e-06	0.000179	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TGFB1—ulcerative colitis	3.85e-06	0.000179	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—STAT3—ulcerative colitis	3.82e-06	0.000178	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TGFB1—ulcerative colitis	3.77e-06	0.000176	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.74e-06	0.000174	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PTGS2—ulcerative colitis	3.73e-06	0.000174	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL2—ulcerative colitis	3.68e-06	0.000172	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—IL6—ulcerative colitis	3.66e-06	0.000171	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TGFB1—ulcerative colitis	3.54e-06	0.000165	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—MMP9—ulcerative colitis	3.48e-06	0.000162	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NFKB1—ulcerative colitis	3.45e-06	0.000161	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	3.32e-06	0.000155	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PPARG—ulcerative colitis	3.28e-06	0.000153	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	3.21e-06	0.00015	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TP53—ulcerative colitis	3.19e-06	0.000149	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TP53—ulcerative colitis	3.17e-06	0.000148	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TP53—ulcerative colitis	3.1e-06	0.000145	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—STAT3—ulcerative colitis	3.1e-06	0.000144	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	3.03e-06	0.000141	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ALB—ulcerative colitis	2.95e-06	0.000137	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IL6—ulcerative colitis	2.92e-06	0.000136	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TP53—ulcerative colitis	2.91e-06	0.000136	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.9e-06	0.000135	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IL6—ulcerative colitis	2.9e-06	0.000135	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	2.89e-06	0.000135	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	2.88e-06	0.000134	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TGFB1—ulcerative colitis	2.87e-06	0.000134	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL6—ulcerative colitis	2.84e-06	0.000132	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	2.74e-06	0.000128	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.71e-06	0.000126	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	2.71e-06	0.000126	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL6—ulcerative colitis	2.67e-06	0.000124	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.58e-06	0.00012	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	2.43e-06	0.000113	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TP53—ulcerative colitis	2.36e-06	0.00011	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	2.26e-06	0.000105	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL6—ulcerative colitis	2.16e-06	0.000101	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.02e-06	9.42e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	1.86e-06	8.66e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ALB—ulcerative colitis	1.82e-06	8.47e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	1.7e-06	7.92e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.59e-06	7.41e-05	CbGpPWpGaD
